Pharma News, 2020

SAN DIEGO, Dec.

GAITHERSBURG, Md.

Shares of Protalix Biotherapeutics were up nearly 7% in premarket trading after the company announced its Phase III BRIDGE study met key objectives in treating Fabry Disease.

Residents of the United Kingdom now have a second vaccine against the novel coronavirus, even as a more virulent strain of COVID-19 sweeps across its lands.

Shares of Aprea Therapeutics plunged more than 77% in morning trading after the Boston-based company announced its late-stage cancer combination treatment failed to meet its primary endpoint of co...

After seeing record COVID-19 deaths and hospitalizations, Los Angeles County will use technology to help residents track and prove their vaccination records, Bloomberg reports.

Scientists have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it difficult to prove this and to pinpoint how it happens.

BEIJING (Reuters) - Drugmakers have agreed to cut prices by around 50% on average for more than 100 medicines in order to have them included in China’s state medical insurance scheme fro...

Shares of Voyager Therapeutics were down nearly 10% in premarket trading after the company announced the U.

The United States now has two authorized vaccines in its arsenal against the novel coronavirus and additional preventative medications are expected to come on line within the next few weeks and months...

The World Health Organization (WHO) indicates there are more than 50 COVID-19 vaccine candidates in clinical trials—the specific number is typically around 74, although other sources cite mo...

Myovant Sciences’ stock rocketed 22% on news it was partnering with Pfizer to develop and commercialize relugolix for prostate cancer and women’s health.